跳至主要内容
临床试验/NCT06360679
NCT06360679招募中不适用

Clinical Feasibility Study of the BariTon™ System in Obese or Overweight (BMI > 27) Patients

BariaTek Medical4 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2024年1月29日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
10
试验地点
4
主要终点
Safety of the BariTon™

研究概览

简要总结

Safety and efficacy evaluation of the BariTon™, BariaTek Medical gastric restriction and biliodigestive diversion device.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
25 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Male and female subjects aged between 25 and 60 years inclusive
  • A BMI between 30.0 and 40.0 kg/m2 inclusive with a history of obesity for at least 2 years and a history of failure of supervised weight loss program
  • Stable weight, i.e. < 5% change in body weight for minimum of 3 months prior to enrolment
  • Willing and able to provide written informed consent
  • Willing and able to comply with the study procedures and follow-up schedule

排除标准

  • 未提供

结局指标

主要结局

Safety of the BariTon™

时间窗: 3 months

Number of patients with device implantation procedure success

次要结局

  • Safety of the BariTon™(1 year)
  • Efficacy of the BariTon™(1 year)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Clinical Feasibility Study of the BariTon™ System in... | 临床试验